Chinese Japanese Germany Korea
ChemicalBook >> CAS DataBase List >>LTX-315

LTX-315

LTX-315 Structure
LTX-315 structure
CAS No.
1345407-05-7
Chemical Name:
LTX-315
Synonyms
LTX-315;Oncopore;Ruxotemitide;LTX-315?, >98%;K-K-W-W-K-K-W-Dip-K-NH2;Ruxotemitide (LTX 315) TFA salt;LTX-315，K-K-W-W-K-K-W-Dip-K-NH2;LTX-315,K-K-W-W-K-K-W-Dip-K-NH2, >98%;L-Lysinamide, L-lysyl-L-lysyl-L-tryptophyl-L-tryptophyl-L-lysyl-L-lysyl-L-tryptophyl-β-phenyl-L-phenylalanyl-;(S)-2,6-Diamino-N-((5S,8S,11S,14S,17S,20S,23S,26S)-11,20,23-tris((1H-indol-3-yl)methyl)-1,30-diamino-14,17-bis(4-aminobutyl)-8-benzhydryl-5-carbamoyl-7,10,13,16,19,22,25-heptaoxo-6,9,12,15,18,21,24-heptaazatriacontan-26-yl)hexanamide
CBNumber:
CB83133752
Molecular Formula:
C78H106N18O9
Molecular Weight:
1439.79
MDL Number:
MFCD30742993
MOL File:
1345407-05-7.mol
Last updated:2024-03-27 11:49:37

LTX-315 Properties

Boiling point 1700.2±65.0 °C(Predicted)
Density 1.263±0.06 g/cm3(Predicted)
storage temp. Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
pka 13.04±0.46(Predicted)
Sequence H-Lys-Lys-Trp-Trp-Lys-Lys-Trp-Dip-Lys-NH2
FDA UNII 75FBL12IZ7

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338

LTX-315 Preparation Products And Raw materials

Raw materials

Preparation Products

1345407-05-7(LTX-315)Related Search:

ANP 1-28, HUMAN Icatibant Acetate Leuprorelin acetate Glucagon Ganirelix Acetate
Degarelix Argireline Plecanatide Ziconotide Polyacetate GLP-1 (7-37)
Cosyntropin Abarelix

1of3

LTX-315 LTX-315,K-K-W-W-K-K-W-Dip-K-NH2, >98% LTX-315?, >98% K-K-W-W-K-K-W-Dip-K-NH2 Oncopore L-Lysinamide, L-lysyl-L-lysyl-L-tryptophyl-L-tryptophyl-L-lysyl-L-lysyl-L-tryptophyl-β-phenyl-L-phenylalanyl- LTX-315，K-K-W-W-K-K-W-Dip-K-NH2 Ruxotemitide (S)-2,6-Diamino-N-((5S,8S,11S,14S,17S,20S,23S,26S)-11,20,23-tris((1H-indol-3-yl)methyl)-1,30-diamino-14,17-bis(4-aminobutyl)-8-benzhydryl-5-carbamoyl-7,10,13,16,19,22,25-heptaoxo-6,9,12,15,18,21,24-heptaazatriacontan-26-yl)hexanamide Ruxotemitide (LTX 315) TFA salt 1345407-05-7 C78H106N18O9